Back to Search
MARY STEIN, PHARMD
PHARMD
Pharmacist
NPI: 1386078921Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
19724(NC)
Clinical Trials (6)
6
Linked Trials
1
Recruiting
3
With Results
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
NCT03781752RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
NCT01816074COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
NCT02675400COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
NCT02255565COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
NCT00663442COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART.
PMID 40009046·J Clin Psychiatry·2025
2-rct
Increased Plasma Concentrations of 6-oxo-Methylphenidate inCarriers Following a Single Oral Dose of Methylphenidate.
PMID 41567292·Med Chem Res·2025
8-other
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
PMID 35201607·Cochrane Database Syst Rev·2022
1-meta
Acute Effects of Parent Stimulant Medication Versus Behavioral Parent Training on Mothers' ADHD, Parenting Behavior, and At-Risk Children.
PMID 32926603·J Clin Psychiatry·2020
4-observational
Striatal Activation Predicts Differential Therapeutic Responses to Methylphenidate and Atomoxetine.
PMID 28647012·J Am Acad Child Adolesc Psychiatry·2017
4-observational
Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
PMID 24942409·J Child Psychol Psychiatry·2015
4-observational
Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders.
PMID 17201617·J Child Adolesc Psychopharmacol·2006
8-other
ADHD symptom subtypes in children with pervasive developmental disorder.
PMID 16477513·J Autism Dev Disord·2006
8-other
Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
PMID 15827573·Neuropsychopharmacology·2005
3-trial
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
PMID 16275814·Arch Gen Psychiatry·2005
4-observational
A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
PMID 14595084·Pediatrics·2003
3-trial
Management of newly diagnosed epilepsy: a practical guide to monotherapy.
PMID 19228076·Drugs·2009
6-review
Relationship of alcohol use and sexual risk taking among hazardously drinking incarcerated women: an event-level analysis.
PMID 19515290·J Stud Alcohol Drugs·2009
8-other
Interaction of Mycoplasma genitalium with host cells: evidence for nuclear localization.
PMID 18832309·Microbiology (Reading)·2008
8-other
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
PMID 18410960·J Allergy Clin Immunol·2008
3-trial
Small cell (neuroendocrine) carcinoma of the prostate: etiology, diagnosis, prognosis, and therapeutic implications--a retrospective study of 30 patients from the rare cancer network.
PMID 19092321·Am J Med Sci·2008
8-other
Relationship of depression to smoking outcomes in a methadone-maintained population.
PMID 17439866·J Addict Dis·2007
2-rct
CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
PMID 17606705·Clin Cancer Res·2007
6-review
Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative.
PMID 17668337·Am J Drug Alcohol Abuse·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 E CORNWALLIS DR
GREENSBORO, NC 27408 - Phone
- (336) 275-9471
Quick Facts
- NPI
- 1386078921
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile